Reuters Novartis said Wednesday that it won't increase the prices of its prescription drugs in the US for the rest of 2018. The decision comes shortly after President Donald Trump called Pfizer out for its recent price increases, prompting and the drugmaker decided to hold off on them. "Right now, in a very dynamic environment in the United States ...we view it as the prudent course right now not to take any further price increases this year," Novartis CEO Vas Narasimhan said.
Novartis Is Putting A Hold On Price Increases To Its Drugs After Trump Called Out One Of Its Rivals (nvs)
Feedburner, Business Insider
Wed, 07/18/2018 - 6:42am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more